Elite Pharmaceuticals, based in Northvale, New Jersey, develops and manufactures abuse-deterrent opioid products and employs 64 staff. Founded in 2014, it specializes in oral, controlled-release drug products and holds multiple generic licenses.
Kirko Kirkov bought 16,366 shares of ELTP on 10 July at $0.59 per share, worth a total of $10K. They now own 16,366 ELTP shares.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
